ID: ALA169550

Max Phase: Preclinical

Molecular Formula: C15H10N3NaO5S

Molecular Weight: 345.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#CCC1=C(C(=O)[O-])N2C(=O)/C(=C/c3ccccn3)C2S(=O)(=O)C1.[Na+]

Standard InChI:  InChI=1S/C15H11N3O5S.Na/c16-5-4-9-8-24(22,23)14-11(7-10-3-1-2-6-17-10)13(19)18(14)12(9)15(20)21;/h1-3,6-7,14H,4,8H2,(H,20,21);/q;+1/p-1/b11-7-;

Standard InChI Key:  BLVBGYMVOISSKK-AJULUCINSA-M

Associated Targets(non-human)

Beta-lactamase class C 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-lactamase TEM 67 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-lactamase 285 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 345.34Molecular Weight (Monoisotopic): 345.0419AlogP: 0.31#Rotatable Bonds: 3
Polar Surface Area: 128.43Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.55CX Basic pKa: 4.30CX LogP: -2.95CX LogD: -4.79
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.62Np Likeness Score: -0.68

References

1. Buynak JD, Doppalapudi VR, Adam G..  (2000)  The synthesis and evaluation of 3-substituted-7-(alkylidene)cephalosporin sulfones as beta-lactamase inhibitors.,  10  (9): [PMID:10853646] [10.1016/s0960-894x(00)00098-6]

Source